Sporadic adult-onset ataxia of unknown etiology

Handbook of Clinical Neurology

Volumn 103, Issue , 2012, Pages 253-262

  Klockgether, Thomas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961146606     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-51892-7.00015-2     Document Type: Chapter

References (99)

1. Abele M., Weller M., Mescheriakov S., et al. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Neurology 1999, 52:857-859.
2. Abele M., Schulz J.B., Bürk K., et al. Evoked potentials in multiple system atrophy (MSA). Acta Neurol. Scand 2000, 101:111-115.
3. Abele M., Bürk K., Schöls L., et al. The aetiology of sporadic adult-onset ataxia. Brain 2002, 125:961-968.
4. Abele M., Schöls L., Schwartz S., et al. Prevalence of antigliadin antibodies in ataxia patients. Neurology 2003, 60:1674-1675.
5. Abele M., Minnerop M., Urbach H., et al. Sporadic adult onset ataxia of unknown etiology: a clinical, electrophysiological and imaging study. J Neurol 2007, 254:1384-1389.
6. Archambault L.S. Parenchymatous atrophy of the cerebellum. J Nerv Ment Dis 1918, 48:273-312.
7. Baloh R.W., Yee R.D., Honrubia V. Late cortical cerebellar atrophy. Clinical and oculographic features. Brain 1986, 109:159-180.
8. Ben Shlomo Y., Wenning G.K., Tison F., et al. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology 1997, 48:384-393.
9. Berciano J. Olivopontocerebellar atrophy. A review of 117 cases. J Neurol Sci 1982, 53:253-272.
10. Berent S., Giordani B., Gilman S., et al. Patterns of neuropsychological performance in multiple system atrophy compared to sporadic and hereditary olivopontocerebellar atrophy. Brain Cogn 2002, 50:194-206.
11. Brussino A., Gellera C., Saluto A., et al. FMR1 gene premutation is a frequent genetic cause of late-onset sporadic cerebellar ataxia. Neurology 2005, 64:145-147.
12. Bürk K., Bösch S., Müller C.A., et al. Sporadic cerebellar ataxia associated with gluten sensitivity. Brain 2001, 124:1013-1019.
13. Bürk K., Globas C., Wahl T., et al. MRI-based volumetric differentiation of sporadic cerebellar ataxia. Brain 2004, 127:175-181.
14. Bürk K., Buhring U., Schulz J.B., et al. Clinical and magnetic resonance imaging characteristics of sporadic cerebellar ataxia. Arch Neurol 2005, 62:981-985.
15. Bushara K.O., Goebel S.U., Shill H., et al. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol 2001, 49:540-543.
16. Catassi C., Fabiani E., Ratsch I.M., et al. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl 1996, 412:29-35.
17. Claus D., Aschoff J.C. Computerized tomography in atrophy of the posterior fossa. Arch Psychiatr Nervenkr 1980, 229:179-187.
18. Claus D., Harding A.E., Hess C.W., et al. Central motor conduction in degenerative ataxic disorders: a magnetic stimulation study. J Neurol Neurosurg Psychiatry 1988, 51:790-795.
19. Combarros O., Infante J., Lopez-Hoyos M., et al. Celiac disease and idiopathic cerebellar ataxia. Neurology 2000, 54:2346.
20. Cruz M.A., Arpa J., Alonso M., et al. Transcranial magnetic stimulation in multiple system and late onset cerebellar atrophies. Acta Neurol Scand 1995, 92:218-224.
21. De Michele G., Filla A., Cavalcanti F., et al. Late onset Friedreich's disease: clinical features and mapping of mutation to the FRDA locus. J Neurol Neurosurg Psychiatry 1994, 57:977-979.
22. Dejerine J., Thomas A. L'atrophie olivo-ponto-cérébelleuse. Nouvelle Iconographie de la Salpetrière 1900, 13:330-370.
23. Della Nave R., Foresti S., Tessa C., et al. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias. Neuroimage 2004, 22:698-705.
24. Dürr A., Cossee M., Agid Y., et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 1996, 335:1169-1175.
25. Fetter M., Klockgether T., Schulz J.B., et al. Oculomotor abnormalities and MRI findings in idiopathic cerebellar ataxia. J Neurol 1994, 241:234-241.
26. Fox S.H., Nieves A., Bergeron C., et al. Pure cerebello-olivary degeneration of Marie, Foix, and Alajouanine presenting with progressive cerebellar ataxia, cognitive decline, and chorea. Mov Disord 2003, 18:1550-1554.
27. Futamura N., Matsumura R., Fujimoto Y., et al. CAG repeat expansions in patients with sporadic cerebellar ataxia. Acta Neurol Scand 1998, 98:55-59.
28. Gilman S., Quinn N.P. The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late-onset cerebellar atrophy. Neurology 1996, 46:1197-1199.
29. Gilman S., Markel D.S., Koeppe R.A., et al. Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography. Ann Neurol 1988, 23:223-230.
30. Gilman S., Koeppe R.A., Junck L., et al. Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy. Ann Neurol 1994, 36:166-175.
31. Gilman S., Low P.A., Quinn N., et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999, 163:94-98.
32. Gilman S., Little R., Johanns J., et al. Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy. Neurology 2000, 55:527-532.
33. Gilman S., Wenning G.K., Low P.A., et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71:670-676.
34. Graham J.G., Oppenheimer D.R. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969, 32:28-34.
35. Hadjivassiliou M., Gibson A., Davies Jones G.A., et al. Does cryptic gluten sensitivity play a part in neurological illness?. Lancet 1996, 347:369-371.
36. Hadjivassiliou M., Boscolo S., Davies-Jones G.A.B., et al. The humoral response in the pathogenesis of gluten ataxia. Neurology 2002, 58:1221-1226.
37. Hadjivassiliou M., Grunewald R., Sharrack B., et al. Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain 2003, 126:685-691.
38. Hagerman R.J., Leavitt B.R., Farzin F., et al. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 2004, 74:1051-1056.
39. Harding A.E. "Idiopathic" late onset cerebellar ataxia. A clinical and genetic study of 36 cases. J Neurol Sci 1981, 51:259-271.
40. Harding A.E., Sura T., Tippett P., et al. Discordance for late-onset degenerative ataxia in monozygous triplets. J Neurol 1991, 238:242-243.
41. Hassin B.S., Bar S.A., Gilad S., et al. Absence of mutations in ATM, the gene responsible for ataxia telangiectasia in patients with cerebellar ataxia. J Neurol 1999, 246:716-719.
42. Hassin-Baer S., Korczyn A.D., Giladi N. An open trial of amantadine and buspirone for cerebellar ataxia: a disappointment. J Neural Transm 2000, 107:1187-1189.
43. Honnorat J., Saiz A., Giometto B., et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies - study of 14 patients. Arch Neurol 2001, 58:225-230.
44. Hovdenak N., Hovlid E., Aksnes L., et al. High prevalence of asymptomatic coeliac disease in Norway: a study of blood donors. Eur J Gastroenterol Hepatol 1999, 11:185-187.
45. Ishida K., Mitoma H., Song S.Y., et al. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol 1999, 46:263-267.
46. Iwabuchi K., Yagishita S. An autopsied case of idiopathic late cortical cerebellar atrophy - comparison with other cortical cerebellar atrophy. Rinsho Shinkeigaku 1990, 30:1190-1196.
47. Jacquemont S., Hagerman R.J., Leehey M., et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet 2003, 72:869-878.
48. Jelgersma G. Eine Systemerkrankung im Kleinhirn. J Psychol Neurol 1919, 25:42-46.
49. Kerber K.A., Jen J.C., Perlman S., et al. Late-onset pure cerebellar ataxia: differentiating those with and without identifiable mutations. J Neurol Sci 2005, 238:41-45.
50. Klockgether T., Schroth G., Diener H.C., et al. Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology. J Neurol Neurosurg Psychiatry 1990, 53:297-305.
51. Klockgether T., Chamberlain S., Wüllner U., et al. Late-onset Friedreich's ataxia. Molecular genetics, clinical neurophysiology, and magnetic resonance imaging. Arch Neurol 1993, 50:803-806.
52. Klockgether T., Bürk K., Schulz J.B., et al. Absence of SCA1 mutation in idiopathic cerebellar ataxia. J Neurol Neurosurg Psychiatry 1994, 57:1439-1440.
53. Klockgether T., Bürk K., Wüllner U., et al. Risk factors for idiopathic cerebellar ataxia of late onset. J Neurol Sci 1998, 160:171-174.
54. Klockgether T., Lüdtke R., Kramer B., et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain 1998, 121:589-600.
55. Lantos P.L., Papp M.I. Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry 1994, 57:129-133.
56. Leone M., Bottacchi E., D'Alessandro G., et al. Hereditary ataxias and paraplegias in Valle d'Aosta, Italy: a study of prevalence and disability. Acta Neurol Scand 1995, 91:183-187.
57. Lhermitte J. L'astasie-abasie cérébelleuse par atrophie vermienne chez le vieillard. Rev Neurol 1922, 29:313-316.
58. Litvan I., Goetz C.G., Jankovic J., et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol 1997, 54:937-944.
59. Litvan I., Booth V., Wenning G.K., et al. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J Neural Transm 1998, 105:217-227.
60. Lou J.S., Goldfarb L., McShane L., et al. Use of buspirone for treatment of cerebellar ataxia - an open-label study. Arch Neurol 1995, 52:982-988.
61. Macpherson J., Waghorn A., Hammans S., et al. Observation of an excess of fragile-X premutations in a population of males referred with spinocerebellar ataxia. Hum Genet 2003, 112:619-620.
62. Marie P., Foix C., Alajouanine T. De l'atrophie cérébelleuse tardive a prédominance corticale. Rev Neurol 1922, 38:849-885.
63. Mondelli M., Decchi B., Parlanti S., et al. Nerve conduction study, electromyography and somatosensory evoked potentials in non-Friedreich early onset cerebellar ataxia. A comparative study with Friedreich's ataxia and late onset cerebellar ataxia. Electromyogr Clin Neurophysiol 1992, 32:207-214.
64. Moseley M.L., Benzow K.A., Schut L.J., et al. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology 1998, 51:1666-1671.
65. Murri A. Degenerazione cerebellare de intossicazione enterogeny. Riv Crit Clin Med 1900, 1:593-608.
66. Muzaimi M.B., Thomas J., Palmer-Smith S., et al. Population based study of late onset cerebellar ataxia in south east Wales. J Neurol Neurosurg Psychiatry 2004, 75:1129-1134.
67. Nabatame H., Fukuyama H., Akiguchi I., et al. Spinocerebellar degeneration: qualitative and quantitative MR analysis of atrophy. J Comput Assist Tomogr 1988, 12:298-303.
68. Ogawa M. Pharmacological treatments of cerebellar ataxia. Cerebellum 2004, 3:107-111.
69. Papp M.I., Lantos P.L. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994, 117:235-243.
70. Papp M.I., Kahn J.E., Lantos P.L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome. J Neurol Sci 1989, 94:79-100.
71. Pellecchia M.T., Scala R., Filla A., et al. Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry 1999, 66:32-35.
72. Penney J.B. Multiple systems atrophy and nonfamilial olivopontocerebellar atrophy are the same disease. Ann Neurol 1995, 37:553-554.
73. Polo J.M., Calleja J., Combarros O., et al. Hereditary ataxias and paraplegias in Cantabria. Spain. An epidemiological and clinical study. Brain 1991, 114:855-866.
74. Pujana M.A., Corral J., Gratacos M., et al. Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. The Ataxia Study Group. Hum Genet 1999, 104:516-522.
75. Quinn N. Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry 1989, 78-89.
76. Ramos A., Quintana F., Diez C., et al. CT findings in spinocerebellar degeneration. Am J Neuroradiol 1987, 8:635-640.
77. Rossi I. Atrophie primitive du cervelet à localisation corticale. Nouv Icon Salp 1907, 20:66-87.
78. Rudolf J., Grond M., Hilker R., et al. Relative sparing of the parietal cortex in cerebellar ataxia documented by positron emission tomography. Clin Neurol Neurosurg 2000, 102:210-214.
79. Saiz A., Arpa J., Sagasta A., et al. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 1997, 49:1026-1030.
80. Schöls L., Szymanski S., Peters S., et al. Genetic background of apparently idiopathic sporadic cerebellar ataxia. Hum Genet 2000, 107:132-137.
81. Schulz J.B., Klockgether T., Petersen D., et al. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry 1994, 57:1047-1056.
82. Sjoberg K., Eriksson S. Regional differences in coeliac disease prevalence in Scandinavia?. Scand J Gastroenterol 1999, 34:41-45.
83. Specht K., Minnerop M., Abele M., et al. In vivo voxel-based morphometry in multiple system atrophy of the cerebellar type. Arch Neurol 2003, 60:1431-1435.
84. Sutton I.J., Last J.I., Ritchie S.J., et al. Adult-onset ataxia telangiectasia due to ATM 5762ins137 mutation homozygosity. Ann Neurol 2004, 55:891-895.
85. Tan E.K., Zhao Y., Puong K.Y., et al. Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort. Neurology 2004, 63:362-363.
86. Thomas A. Atrophie lamellaire des cellules de Purkinje. Rev Neurol 1905, 13:917-924.
87. Trouillas P., Brudon F., Adeleine P. Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. A double-blind study with quantified data processing. Arch Neurol 1988, 45:1217-1222.
88. Trouillas P., Xie J., Adeleine P., et al. Buspirone, a 5-hydroxytryptamine1A agonist, is active in cerebellar ataxia - results of a double-blind drug placebo study in patients with cerebellar cortical atrophy. Arch Neurol 1997, 54:749-752.
89. Tu P.H., Galvin J.E., Baba M., et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 1998, 44:415-422.
90. Van Esch H., Dom R., Bex D., et al. Screening for FMR-1 premutations in 122 older Flemish males presenting with ataxia. Eur J Hum Genet 2005, 13:121-123.
91. Villanueva-Haba V., Garces-Sanchez M., Bataller L., et al. Neuroimaging study with morphometric analysis of hereditary and idiopathic ataxia. Neurologia 2001, 16:105-111.
92. Watanabe H., Saito Y., Terao S., et al. Progression and prognosis in multiple system atrophy - an analysis of 230 Japanese patients. Brain 2002, 125:1070-1083.
93. Wenning G.K., Ben Shlomo Y., Magalhaes M., et al. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994, 117:835-845.
94. Wenning G.K., Tison F., Ben Shlomo Y., et al. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997, 12:133-147.
95. Wenning G.K., Ben Shlomo Y., Hughes A., et al. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?. J Neurol Neurosurg Psychiatry 2000, 68:434-440.
96. Wessel K., Huss G.P., Bruckmann H., et al. Follow-up of neurophysiological tests and CT in late-onset cerebellar ataxia and multiple system atrophy. J Neurol 1993, 240:168-176.
97. Wessel K., Hermsdörfer J., Deger K., et al. Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases. Arch Neurol 1995, 52:451-455.
98. Wiendl H., Mehling M., Dichgans J., et al. Cerebellar ataxia associated with gluten sensitivity: no evidence for humoral immune reactivity to cerebellar neurons. Neurology 2002, 60:1397.
99. Wüllner U., Klockgether T., Petersen D., et al. Magnetic resonance imaging in hereditary and idiopathic ataxia. Neurology 1993, 43:318-325.